Diaminoalkane aspartic protease inhibitors
US7754737B2 · kind B2 · utility
5Cited by
9References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2005 |
| Grant date | Jul 13, 2010 |
| Priority date | — |
| Expiry date | Dec 7, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Diaminoalkanes of Formula I have now been found which are orally active and bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with elevated levels of aspartic protease activity. The invention also relates to a method for the use of the compounds of Formula I in ameliorating or treating aspartic protease related disorders in a subject in need thereof comprising administering to said subject an effective amount of a compound of Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.